- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Masks May Never Go, warns ICMR chief Balram Bhargava
"We don't know how much of the population we'll have to vaccinate to break the virus transmission," ICMR Chief, Balram Bhargava said.
New Delhi: Days after two vaccines were approved under restricted use and emergency use authorization by Directorate General of Civil Aviation (DGCA), Dr Balram Bhargava, Director General of Indian Council of Medical Research (ICMR), on Sunday said masks may never go out of regular usage.
"I think it's a great day for India, it's a great day for humanity at large. Two vaccines have been approved under restricted use and emergency use authorisation and it has been done following discussions by SEC. This is wonderful news for India and all of us," Bhargava told ANI.
However, he said that it is unknown how long a vaccine is going to be effective. "We don't know how much of the population we'll have to vaccinate to break the virus transmission. What we know is that we've been able to control the pandemic in the country by following COVID-19 appropriate behavior... I am of the opinion that masks will probably be the last to go and probably may never even go."
Talking about the new variant of Crornavirus creating 'havoc' in the UK, the ICMR chief informed that scientists of the National Institute of Virology (NIV) have successfully isolated the new virus strain and it will be tested against different vaccines soon.
"New virus variant which is now more than 60 percent infective and creating havoc in the UK, is worrisome. There are 29 patients in India with the same variant for which we should be cautious. We were able to isolate the new virus very early," he stated.
"NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines," he said and added that he hopes "potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain because it is a whole virus."
ICMR on Saturday said India has successfully isolated and cultured the UK-variant of Sars-CoV-2, the virus that causes COVID-19 disease. It is to mention that no other country has yet reported successful isolation and culture of the UK-variant of SARS-CoV-2 and added that vero cell lines of the virus were used by the scientists of ICMR-NIV to culture the UK-variant of the virus.
COVID-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation, said Drugs Controller General of India (DCGI) on Sunday.
Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.